Brian C. Goh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brian C. Goh has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey M. Gimble
Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA
9 shared publications Xiying Wu
Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA
6 shared publicationsGail Kilroy
Stem Cell Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana
5 shared publicationsSanjin Zvonic
Stem Cell Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana
4 shared publications- Z. Elizabeth Floyd
Pennington Biomedical Research Center, Baton Rouge, USA
4 shared publications - Grace X. Xiong
Department of Orthopaedic Surgery, Stanford University, Redwood City, CA 94063, USA
3 shared publications
Latest Publications
- 20 July 2026
- Published by Elsevier in The Spine Journal
- Vol. 26 (11) , 2144-2156
Low dose rhBMP-2 use in 3- and 4-level ACDF without posterior fusion: a comparative analysis and viable treatment for multilevel cervical disease
- 20 July 2026
- Published by Elsevier in The Spine Journal
- Vol. 26 (11) , 2144-2156
Low dose rhBMP-2 use in 3- and 4-level ACDF without posterior fusion: a comparative analysis and viable treatment for multilevel cervical disease
- 22 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 184, e211-e218
What Happens to Sagittal Alignment Following Laminoplasty Versus Laminectomy and Fusion?
- 22 January 2024
- Published by Elsevier in World Neurosurgery
- Vol. 184, e211-e218
What Happens to Sagittal Alignment Following Laminoplasty Versus Laminectomy and Fusion?
- Open Access
- 4 December 2023
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 1 (6) , qxad068
Massachusetts’ opioid limit law associated with a reduction in postoperative opioid duration among orthopedic patients
Postoperative orthopedic patients are a high-risk group for receiving long-duration, large-dosage opioid prescriptions. Rigorous evaluation of state opioid duration limit laws, enacted throughout the country in response to the opioid overdose epidemic, is lacking among this high-risk group. We took advantage of Massachusetts’ early implementation of a 2016 7-day-limit law that occurred before other statewide or plan-wide policies took effect and used commercial insurance claims from 2014–2017 to study its association with postoperative opioid prescriptions greater than 7 days’ duration among Massachusetts orthopedic patients relative to a New Hampshire control group. Our sample included 14 097 commercially insured, opioid-naive adults aged 18 years and older undergoing elective orthopedic procedures. We found that the Massachusetts 7-day limit was associated with an immediate 4.23 percentage point absolute reduction (95% CI, 8.12 to 0.33 percentage points) and a 33.27% relative reduction (95% CI, 55.36% to 11.19%) in the percentage of initial fills greater than 7 days in the Massachusetts relative to the control group. Seven-day-limit laws may be an important state-level tool to mitigate longer duration prescribing to high-risk postoperative populations.
- 4 December 2023
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 1 (6) , qxad068
Open AccessMassachusetts’ opioid limit law associated with a reduction in postoperative opioid duration among orthopedic patients
Postoperative orthopedic patients are a high-risk group for receiving long-duration, large-dosage opioid prescriptions. Rigorous evaluation of state opioid duration limit laws, enacted throughout the country in response to the opioid overdose epidemic, is lacking among this high-risk group. We took advantage of Massachusetts’ early implementation of a 2016 7-day-limit law that occurred before other statewide or plan-wide policies took effect and used commercial insurance claims from 2014–2017 to study its association with postoperative opioid prescriptions greater than 7 days’ duration among Massachusetts orthopedic patients relative to a New Hampshire control group. Our sample included 14 097 commercially insured, opioid-naive adults aged 18 years and older undergoing elective orthopedic procedures. We found that the Massachusetts 7-day limit was associated with an immediate 4.23 percentage point absolute reduction (95% CI, 8.12 to 0.33 percentage points) and a 33.27% relative reduction (95% CI, 55.36% to 11.19%) in the percentage of initial fills greater than 7 days in the Massachusetts relative to the control group. Seven-day-limit laws may be an important state-level tool to mitigate longer duration prescribing to high-risk postoperative populations.
- 19 August 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (9) , S21
41. Impact of insurance type on patient-reported outcome measures in patients with lumbar disc herniation
- 19 August 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (9) , S21
41. Impact of insurance type on patient-reported outcome measures in patients with lumbar disc herniation
- 26 March 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (8) , 1309-1317
Impact of insurance type on patient-reported outcome measures in patients with lumbar disc herniation
- 26 March 2022
- Published by Elsevier in The Spine Journal
- Vol. 22 (8) , 1309-1317
Impact of insurance type on patient-reported outcome measures in patients with lumbar disc herniation
- 1 April 2021
- Published by Elsevier in The Spine Journal
- Vol. 21 (4) , 571-577
Laminoplasty—an underutilized procedure for cervical spondylotic myelopathy
- 1 April 2021
- Published by Elsevier in The Spine Journal
- Vol. 21 (4) , 571-577
Laminoplasty—an underutilized procedure for cervical spondylotic myelopathy
- 1 November 2020
- Published by Elsevier in The Spine Journal
- Vol. 20 (11) , 1770-1775
Laminoplasty versus laminectomy and fusion for cervical spondylotic myelopathy: a cost analysis
- 1 November 2020
- Published by Elsevier in The Spine Journal
- Vol. 20 (11) , 1770-1775
Laminoplasty versus laminectomy and fusion for cervical spondylotic myelopathy: a cost analysis
- 24 February 2020
- Published by Wolters Kluwer Health in Spine
- Vol. 45 (15) , E959-E966
The Prognostic Value of Laboratory Markers and Ambulatory Function at Presentation for Post-Treatment Morbidity and Mortality Following Epidural Abscess
Study Design.: Retrospective cohort study. Objective.: To develop a comprehensive understanding of the prognostic value of laboratory markers on morbidity and mortality following epidural abscess. Summary of Background Data.: Spinal epidural abscess is a serious medical condition with high rates of morbidity. The value of laboratory data in forecasting morbidity and mortality after epidural abscess remains underexplored. Methods.: We obtained clinical data on patients treated for epidural abscess at two academic centers from 2005 to 2017. Our primary outcome was the development of one or more complications within 90-days of presentation, with mortality a secondary measure. Primary predictors included serum albumin, serum creatinine, platelet–lymphocyte ratio, and ambulatory status at presentation. We used multivariable logistic regression techniques to adjust for confounders. The most parsimonious set of variables influencing both complications and mortality were considered to be clinically significant. These were then examined individually and in combination to assess for synergy along with model-discrimination and calibration. We performed internal validation with a bootstrap procedure using sampling with replacement. Results.: We included 449 patients in this analysis. Complications were encountered in 164 cases (37%). Mortality within 1-year occurred in 39 patients (9%). Regression testing determined that serum albumin, serum creatinine, and ambulatory status at presentation were clinically important predictors of outcome, with albumin more than 3.5 g/dL, creatinine less than or equal to 1.2 mg/dL, and independent ambulatory function at presentation considered favorable characteristics. Patients with no favorable findings had increased likelihood of 90-day complications (odds ratio [OR] 5.43; 95% confidence intervals [CI] 1.98, 14.93) and 1-year mortality (OR 8.94; 95% CI 2.03, 39.37). Those with one favorable characteristic had greater odds of complications (OR 4.00; 95% CI 2.05, 7.81) and mortality (OR 5.71; 95% CI 1.60, 20.43). Conclusion.: We developed a nomogram incorporating clinical and laboratory values to prognosticate outcomes after treatment for epidural abscess. The results can be used in shared-decision making and counseling. Level of Evidence: 3
- 24 February 2020
- Published by Wolters Kluwer Health in Spine
- Vol. 45 (15) , E959-E966
The Prognostic Value of Laboratory Markers and Ambulatory Function at Presentation for Post-Treatment Morbidity and Mortality Following Epidural Abscess
Study Design.: Retrospective cohort study. Objective.: To develop a comprehensive understanding of the prognostic value of laboratory markers on morbidity and mortality following epidural abscess. Summary of Background Data.: Spinal epidural abscess is a serious medical condition with high rates of morbidity. The value of laboratory data in forecasting morbidity and mortality after epidural abscess remains underexplored. Methods.: We obtained clinical data on patients treated for epidural abscess at two academic centers from 2005 to 2017. Our primary outcome was the development of one or more complications within 90-days of presentation, with mortality a secondary measure. Primary predictors included serum albumin, serum creatinine, platelet–lymphocyte ratio, and ambulatory status at presentation. We used multivariable logistic regression techniques to adjust for confounders. The most parsimonious set of variables influencing both complications and mortality were considered to be clinically significant. These were then examined individually and in combination to assess for synergy along with model-discrimination and calibration. We performed internal validation with a bootstrap procedure using sampling with replacement. Results.: We included 449 patients in this analysis. Complications were encountered in 164 cases (37%). Mortality within 1-year occurred in 39 patients (9%). Regression testing determined that serum albumin, serum creatinine, and ambulatory status at presentation were clinically important predictors of outcome, with albumin more than 3.5 g/dL, creatinine less than or equal to 1.2 mg/dL, and independent ambulatory function at presentation considered favorable characteristics. Patients with no favorable findings had increased likelihood of 90-day complications (odds ratio [OR] 5.43; 95% confidence intervals [CI] 1.98, 14.93) and 1-year mortality (OR 8.94; 95% CI 2.03, 39.37). Those with one favorable characteristic had greater odds of complications (OR 4.00; 95% CI 2.05, 7.81) and mortality (OR 5.71; 95% CI 1.60, 20.43). Conclusion.: We developed a nomogram incorporating clinical and laboratory values to prognosticate outcomes after treatment for epidural abscess. The results can be used in shared-decision making and counseling. Level of Evidence: 3
- 29 November 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (22) , 2987-3006
Nanomaterials for Bone Tissue Regeneration: Updates and Future Perspectives
Joint replacement and bone reconstructive surgeries are on the rise globally. Current strategies for implants and bone regeneration are associated with poor integration and healing resulting in rep...
- 29 November 2019
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (22) , 2987-3006
Nanomaterials for Bone Tissue Regeneration: Updates and Future Perspectives
Joint replacement and bone reconstructive surgeries are on the rise globally. Current strategies for implants and bone regeneration are associated with poor integration and healing resulting in rep...
- 1 October 2017
- Published by Elsevier in The Spine Journal
- Vol. 17 (10) , S225
Utilizing the Fracture Risk Assessment Tool (FRAX) to Assess Risk of Proximal Junctional Kyphosis in Adult Spinal Deformity Surgery
- 1 October 2017
- Published by Elsevier in The Spine Journal
- Vol. 17 (10) , S225
Utilizing the Fracture Risk Assessment Tool (FRAX) to Assess Risk of Proximal Junctional Kyphosis in Adult Spinal Deformity Surgery